Nonalcoholic fatty liver disease
Conditions
Interventions
Observation group:Routine treatment + Qianggan capsule
Sponsors
Longhua Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Eligibility
Sex/Gender
Male
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Meet the diagnostic criteria of NAFLD in western medicine; Age 18-80 years old; Unlimited gender; The subjects agreed to join the clinical study, voluntarily signed the informed consent form, and agreed to participate in the visit, examination and treatment according to the requirements of the research plan.
Exclusion criteria
Exclusion criteria: Pregnant and lactating women; Patients considered unsuitable by the investigator to participate in this study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes of TCM syndrome score before and after treatment;Proportion of patients whose ALT level returned to normal (= 40u / L) or whose ALT level decreased by = 30%;The change of triglyceride (TG) ratio before and after treatment and the proportion of patients who returned to normal (= 1.88 mmol / L) after treatment.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes of liver imaging (CT, MRI, transient elasticity, B-ultrasound, etc.) before and after treatment; | — |
Countries
china
Contacts
Public Contactguang Ji
Longhua Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Outcome results
None listed